Clinical trial

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

NCT04958811

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Tiragolumab Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Atezolizumab Normalized identity: atezolizumabView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Bevacizumab Normalized identity: bevacizumabView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2021-12-21

PhasePHASE2

Conditions

Non-squamous Non-small-cell Lung Cancerunresolved

Interventions

TiragolumabDRUG

AtezolizumabDRUG · verified · RxNorm: atezolizumab

BevacizumabDRUG · verified · RxNorm: bevacizumab

Sponsors & collaborators

Georgetown Universitylead sponsor

Genentech, Inc.collaborator

Mapped research locations

Washington D.C.District of Columbia, United States1 HackensackNew Jersey, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04958811 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.